The Beauty Health Company (SKIN) — Financial statements
Income statement, balance sheet, and cash flow for The Beauty Health Company — annual and quarterly history with growth and margin analysis.
| Metric (USD Millions) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 301↓10.0% | 334↓16.0% | 398↑8.8% | 366↑40.7% | 260 | |
| Cost of Revenue | 104↓31.3% | 152↓37.4% | 243↑107.4% | 117↑43.6% | 82 | |
| Gross Profit | 196↑7.7% | 182↑17.5% | 155↓37.7% | 249↑39.3% | 179 | |
| Operating Expenses | ||||||
| R&D Expenses | 6↓10.6% | 6↓37.7% | 10↑19.6% | 8↑3.0% | 8 | |
| General & Administrative Expenses | 118↓6.0% | 125↓4.5% | 131↑23.9% | 106↑7.5% | 99 | |
| Selling & Marketing Expenses | 94↓20.9% | 118↓18.1% | 144↓9.7% | 160↑43.5% | 112 | |
| SG&A Expenses | 212↓13.2% | 244↓11.7% | 276↑3.7% | 266↑26.6% | 210 | |
| Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Operating Expenses | 217↓13.2% | 250↓12.6% | 286↑4.2% | 275↑25.7% | 218 | |
| Total Costs & Expenses | 322↓20.0% | 402↓24.0% | 529↑35.0% | 392↑30.6% | 300 | |
| Operating Results | ||||||
| Operating Income | -21↑69.3% | -68↑48.2% | -131↓406.6% | -26↑35.3% | -40 | |
| Depreciation & Amortization | 25↓14.0% | 29↓15.0% | 35↑51.6% | 23↑27.6% | 18 | |
| EBITDA | 39↑274.7% | 10↑119.3% | -54↓165.6% | 82↑123.3% | -351 | |
| EBIT | 13↑170.0% | -19↑78.3% | -88↓250.2% | 59↑115.9% | -369 | |
| Interest & Other Income | ||||||
| Net Interest Income | -10↓266.4% | 6↓34.6% | 10↑325.8% | -4↑64.1% | -12 | |
| Interest Income | 9↓46.2% | 17↓28.2% | 23↑152.6% | 9↑23425.6% | 0.04 | |
| Interest Expense | 19↑85.6% | 10↓23.7% | 14↑1.9% | 13↑13.7% | 12 | |
| Non-Operating Income | -34↑29.7% | -49↓14.0% | -43↑49.5% | -85↓125.7% | 329 | |
| Other Income / Expenses | 15↓61.1% | 38↑31.7% | 29↓59.2% | 71↑120.9% | -341 | |
| Income Before Tax | -6↑79.9% | -30↑71.0% | -102↓324.7% | 45↑111.9% | -381 | |
| Income Tax Expense | 4↑892.3% | -0.45↑74.5% | -2↓259.0% | 1↑159.5% | -2 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | -10↑67.3% | -29↑70.9% | -100↓326.4% | 44↑111.7% | -379 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | -10↑67.3% | -29↑70.9% | -100↓326.4% | 44↑111.7% | -379 | |
| Bottom-Line Net Income | -22↑57.3% | -52↑48.3% | -100↓193.4% | -34↑91.0% | -379 | |
| EPS (Basic) | -0.08↑65.2% | -0.23↑69.7% | -0.76↓353.3% | 0.30↑108.2% | -3.67 | |
| EPS (Diluted) | -0.16↑55.6% | -0.36↑52.6% | -0.76↓230.4% | -0.23↑93.7% | -3.67 | |
| Weighted Average Shares | 126↑2.1% | 124↓6.0% | 132↓10.8% | 148↑44.5% | 102 | |
| Weighted Average Diluted Shares | 136↓4.7% | 142↑8.2% | 132↓11.3% | 149↑45.4% | 102 | |
* All figures in Millions of USD, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.